Showing 1 - 20 results of 128,429 for search '(( significant clinical based ) OR ( significant ((gap decrease) OR (_ decrease)) ))', query time: 2.38s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”
  7. 7

    Overexpression of Gαq decreases cell number and cell size. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    “…Student t-test was used for statistical significance testing.</p> <p>(TIF)</p>…”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Syndecan ectodomain fragments decrease endothelial resistance via rho kinase. by Melanie Jannaway (6703577)

    Published 2019
    “…(B) rhS3ED fragments induced a highly significant drop in TER (n = 6, p<0.0001). (C) rhS4ED fragments significantly decreased TER (n = 8, p = 0.0002). …”
  13. 13

    Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

    Published 2023
    “…Samples were separated based on clinical outcome (X-axis, orange treatment responsive, teal treatment non-responsive). …”
  14. 14

    Table1_Clinical Significance of TET2 in Female Cancers.docx by Fang Wan (779615)

    Published 2022
    “…Therefore, this study aimed to summarize the clinical value and underlying oncogenic functions of TET2 in female cancers, such as breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), ovarian serous cystadenocarcinoma (OV), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS), based on the data obtained from The Cancer Genome Atlas. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20